 Home > Active Ingredient News > Immunology News > Chinese medicine acyclovir for injection passed the consistency evaluation of generic drugs

Chinese medicine acyclovir for injection passed the consistency evaluation of generic drugs

 Last Update: 2021-06-06
 Source: Internet
 Author: User

Tags

cc drug

what drug monograph

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 2, China Pharmaceuticals issued an announcement stating that its subsidiary, Keyi Pharmaceutical, had obtained the "Notice of Approval of Supplementary Application for Drug Application" for acyclovir for injection approved and issued by the State Food and Drug Administration.

Acyclovir is an antiviral drug used to treat herpes.

According to the query data from Zhongkang, the domestic sales of acyclovir for injection in 2020 will be approximately 18.

18.
37 million yuan.
The sales revenue of this drug in China Pharmaceuticals in 2020 is approximately RMB 2.
8376 million.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.